Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
The aims of the present study were to examine whether the pattern of syndecan‐1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) an...
Saved in:
Published in: | Pathology international Vol. 59; no. 4; pp. 229 - 233 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Melbourne, Australia
Blackwell Publishing Asia
01-04-2009
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The aims of the present study were to examine whether the pattern of syndecan‐1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma. Immunohistochemistry was performed for syndecan‐1 and Ki‐67 in seven ameloblastomas (four DA and three PA) and three AC. Expression of syndecan‐1 was related to the histological subtype of tumors and, in the case of malignancy, to lower expression levels observed in AC (22.5%) than in PA (47.5%) or DA (77.5%) (P < 0.05). Syndecan‐1 expression correlated inversely with Ki‐67 proliferative index: the expression was lower in both types of ameloblastomas (1.5% in DA and 6.4% in PA) than in AC (41.2%; P < 0.05). The present results suggest that the decrease in syndecan‐1 expression and increase in the Ki‐67 index observed in AC is in accordance with its higher aggressiveness as compared to the rare DA and PA. Interestingly, DA had a lower proliferation index as well as the highest levels of syndecan‐1 expression. These data suggest that DA differ from the other types of intraosseous ameloblastomas but more studies are necessary to better understand the role of this protein as a marker in the biological behavior of the epithelial odontogenic neoplasms. |
---|---|
AbstractList | The aims of the present study were to examine whether the pattern of syndecan‐1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma. Immunohistochemistry was performed for syndecan‐1 and Ki‐67 in seven ameloblastomas (four DA and three PA) and three AC. Expression of syndecan‐1 was related to the histological subtype of tumors and, in the case of malignancy, to lower expression levels observed in AC (22.5%) than in PA (47.5%) or DA (77.5%) (
P
< 0.05). Syndecan‐1 expression correlated inversely with Ki‐67 proliferative index: the expression was lower in both types of ameloblastomas (1.5% in DA and 6.4% in PA) than in AC (41.2%;
P
< 0.05). The present results suggest that the decrease in syndecan‐1 expression and increase in the Ki‐67 index observed in AC is in accordance with its higher aggressiveness as compared to the rare DA and PA. Interestingly, DA had a lower proliferation index as well as the highest levels of syndecan‐1 expression. These data suggest that DA differ from the other types of intraosseous ameloblastomas but more studies are necessary to better understand the role of this protein as a marker in the biological behavior of the epithelial odontogenic neoplasms. The aims of the present study were to examine whether the pattern of syndecan-1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma. Immunohistochemistry was performed for syndecan-1 and Ki-67 in seven ameloblastomas (four DA and three PA) and three AC. Expression of syndecan-1 was related to the histological subtype of tumors and, in the case of malignancy, to lower expression levels observed in AC (22.5%) than in PA (47.5%) or DA (77.5%) (P < 0.05). Syndecan-1 expression correlated inversely with Ki-67 proliferative index: the expression was lower in both types of ameloblastomas (1.5% in DA and 6.4% in PA) than in AC (41.2%; P < 0.05). The present results suggest that the decrease in syndecan-1 expression and increase in the Ki-67 index observed in AC is in accordance with its higher aggressiveness as compared to the rare DA and PA. Interestingly, DA had a lower proliferation index as well as the highest levels of syndecan-1 expression. These data suggest that DA differ from the other types of intraosseous ameloblastomas but more studies are necessary to better understand the role of this protein as a marker in the biological behavior of the epithelial odontogenic neoplasms. The aims of the present study were to examine whether the pattern of syndecan-1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma. Immunohistochemistry was performed for syndecan-1 and Ki-67 in seven ameloblastomas (four DA and three PA) and three AC. Expression of syndecan-1 was related to the histological subtype of tumors and, in the case of malignancy, to lower expression levels observed in AC (22.5%) than in PA (47.5%) or DA (77.5%) (P < 0.05). Syndecan-1 expression correlated inversely with Ki-67 proliferative index: the expression was lower in both types of ameloblastomas (1.5% in DA and 6.4% in PA) than in AC (41.2%; P < 0.05). The present results suggest that the decrease in syndecan-1 expression and increase in the Ki-67 index observed in AC is in accordance with its higher aggressiveness as compared to the rare DA and PA. Interestingly, DA had a lower proliferation index as well as the highest levels of syndecan-1 expression. These data suggest that DA differ from the other types of intraosseous ameloblastomas but more studies are necessary to better understand the role of this protein as a marker in the biological behavior of the epithelial odontogenic neoplasms. |
Author | De Almeida, Oslei Paes Farfán-Morales, José E. Mosqueda-Taylor, Adalberto Lopez-Corella, Eduardo Damián-Matsumura, Pablo Carrasco-Daza, Daniel Molina-Frechero, Nelly Bologna-Molina, Ronell |
Author_xml | – sequence: 1 givenname: Ronell surname: Bologna-Molina fullname: Bologna-Molina, Ronell organization: Department of Biological and Health Sciences, Universidad Autónoma Metropolitana – sequence: 2 givenname: Adalberto surname: Mosqueda-Taylor fullname: Mosqueda-Taylor, Adalberto organization: Health Care Department, Universidad Autónoma Metropolitana Xochimilco – sequence: 3 givenname: Eduardo surname: Lopez-Corella fullname: Lopez-Corella, Eduardo organization: Laboratory of Molecular Pathology, Instituto Nacional de Pediatria – sequence: 4 givenname: Oslei Paes surname: De Almeida fullname: De Almeida, Oslei Paes organization: Department of Oral Diagnosis, Oral Pathology Section, School of Dentistry of Piracicaba, UNICAMP. Piracicaba, Sao Paolo State, Brazil and – sequence: 5 givenname: Daniel surname: Carrasco-Daza fullname: Carrasco-Daza, Daniel organization: Laboratory of Molecular Pathology, Instituto Nacional de Pediatria – sequence: 6 givenname: José E. surname: Farfán-Morales fullname: Farfán-Morales, José E. organization: Laboratory of Molecular Pathology, Instituto Nacional de Pediatria – sequence: 7 givenname: Nelly surname: Molina-Frechero fullname: Molina-Frechero, Nelly organization: Health Care Department, Universidad Autónoma Metropolitana Xochimilco – sequence: 8 givenname: Pablo surname: Damián-Matsumura fullname: Damián-Matsumura, Pablo organization: Department of Biology of Reproduction, Universidad Autónoma Metropolitana Iztapalapa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19351365$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUU1v1DAQtVAR_aB_AeXELcEfcT4OHNBCS9WycKDq0ZrYE-ElsYO9S3f_fZ3dVXuEOdjjee_N2H7n5MR5h4RkjBYsxYdVwcqS5qzhdcEpbQvKhZTF9hU5ewZOUi44zWVZiVNyHuOKUlaLir4hp6wVkolKnpHHhR8nCLC2fzHD7RQwRutd5vss7pxBDS5nGTiT3dq8qjPrsgmDnX5hgGFfNxhHPw0Q11ZnMOLgu_ngR4h7_KWUcA1BW5ewt-R1D0PEy-N-Qe6vvvxcfM3vvl_fLD7d5VqmyDU1UGFZdr2Gmrcc0yJ1unwHRlLTGMFkKvVCCw3cMM5Y24pe0AZq2nUoLsj7Q98p-D8bjGs12qhxGMCh30RV1YzRsmz_SeQ0fSSraSI2B6IOPsaAvZqCHSHsFKNqdket1GyCmk1Qsztq747aJum744xNN6J5ER7tSISPB8KjHXD3343Vj5vlnCV9ftDbuMbtsx7C7_RQUUv1sLxWt027fPicWnwTTw6Yr8Y |
CitedBy_id | crossref_primary_10_1111_jicd_12282 crossref_primary_10_4103_EGJP_EGJP_10_21 crossref_primary_10_1016_j_anndiagpath_2009_10_007 crossref_primary_10_1111_odi_12733 crossref_primary_10_1089_cbr_2011_1018 crossref_primary_10_1016_j_ajoms_2022_06_010 crossref_primary_10_1016_j_oooo_2013_08_023 crossref_primary_10_3390_ijerph18083899 crossref_primary_10_1097_PAI_0000000000000042 crossref_primary_10_1111_his_12995 crossref_primary_10_1016_j_maxilo_2014_03_005 crossref_primary_10_1186_1746_1596_8_50 crossref_primary_10_1016_j_oooo_2015_05_011 crossref_primary_10_1016_j_prp_2012_09_001 crossref_primary_10_4103_jomfp_JOMFP_289_19 crossref_primary_10_1111_jop_12428 crossref_primary_10_1016_j_tripleo_2011_06_036 crossref_primary_10_1155_2018_7048531 crossref_primary_10_1111_j_1365_2559_2011_03954_x crossref_primary_10_1111_j_1600_0714_2010_00908_x crossref_primary_10_1016_j_oooo_2015_09_021 crossref_primary_10_1111_j_1600_0714_2012_01195_x crossref_primary_10_1016_j_oooo_2018_09_009 crossref_primary_10_1155_2013_604560 crossref_primary_10_1177_014556131409300908 crossref_primary_10_1155_2015_683087 crossref_primary_10_1177_1066896914553663 crossref_primary_10_1007_s12105_010_0173_7 crossref_primary_10_1016_j_ajoms_2021_03_007 crossref_primary_10_1007_s12663_016_0923_5 crossref_primary_10_1007_s12105_014_0582_0 crossref_primary_10_1016_j_oraloncology_2022_106122 crossref_primary_10_1007_s40496_016_0087_x crossref_primary_10_1016_j_joms_2013_11_029 crossref_primary_10_1016_j_oooo_2014_01_021 crossref_primary_10_1016_j_oooo_2015_11_015 crossref_primary_10_1590_0103_6440201300024 crossref_primary_10_1111_odi_12130 crossref_primary_10_1111_odi_12010 |
Cites_doi | 10.1038/sj.bjc.6690088 10.1111/j.1600-0714.2007.00537.x 10.1016/S1368-8375(00)00111-1 10.1242/dev.119.3.841 10.1016/0964-1955(94)90064-7 10.1002/cncr.20542 10.1083/jcb.106.2.423 10.1016/0012-1606(88)90401-0 10.1016/S1368-8375(00)00064-6 10.1016/0014-4827(92)90194-D 10.1006/excr.1994.1330 10.1177/35.10.2957423 10.1016/0012-1606(89)90110-3 10.4103/0970-9290.35836 10.1111/j.1601-0825.2006.01284.x 10.1083/jcb.108.5.1945 10.1016/j.oraloncology.2007.10.007 10.1016/S0021-9258(18)42715-9 10.1111/j.0904-2512.2004.00178.x 10.1902/jop.1995.66.12.1065 10.1111/j.1600-0714.2006.00412.x 10.1016/S0021-9258(18)80001-1 10.1016/j.ijom.2005.06.020 10.1016/S0021-9258(17)39576-5 10.1002/pros.10209 10.1016/0278-2391(91)90061-P 10.1016/S0901-5027(87)80131-5 10.1016/S0021-9258(20)89510-6 10.1016/0030-4220(84)90207-X 10.1016/j.tripleo.2007.05.026 10.1083/jcb.118.4.961 10.1146/annurev.biochem.68.1.729 |
ContentType | Journal Article |
Copyright | 2009 The Authors. Journal compilation © 2009 Japanese Society of Pathology |
Copyright_xml | – notice: 2009 The Authors. Journal compilation © 2009 Japanese Society of Pathology |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7X8 |
DOI | 10.1111/j.1440-1827.2009.02355.x |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1440-1827 |
EndPage | 233 |
ExternalDocumentID | 10_1111_j_1440_1827_2009_02355_x 19351365 PIN2355 ark_67375_WNG_K89NWD27_M |
Genre | article Journal Article Comparative Study |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 123 1OB 1OC 29O 31~ 33P 36B 3O- 3SF 3UE 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHTB AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPEJ ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA GSXLS H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YUY ZGI ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7QP 7X8 |
ID | FETCH-LOGICAL-c5555-c0da6e44bfca7292e7295c351bad50d8d315729f3c3ca2d1211993f308a70bbe3 |
IEDL.DBID | 33P |
ISSN | 1320-5463 |
IngestDate | Fri Aug 16 11:22:12 EDT 2024 Fri Aug 16 09:24:38 EDT 2024 Fri Nov 22 00:40:26 EST 2024 Sat Sep 28 07:45:10 EDT 2024 Sat Aug 24 00:54:06 EDT 2024 Wed Oct 30 09:52:49 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5555-c0da6e44bfca7292e7295c351bad50d8d315729f3c3ca2d1211993f308a70bbe3 |
Notes | ArticleID:PIN2355 ark:/67375/WNG-K89NWD27-M istex:7853E2DB11ACD06AE9D8F0DB1DCA025C8842B4CD ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19351365 |
PQID | 20546170 |
PQPubID | 23462 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_67110449 proquest_miscellaneous_20546170 crossref_primary_10_1111_j_1440_1827_2009_02355_x pubmed_primary_19351365 wiley_primary_10_1111_j_1440_1827_2009_02355_x_PIN2355 istex_primary_ark_67375_WNG_K89NWD27_M |
PublicationCentury | 2000 |
PublicationDate | April 2009 |
PublicationDateYYYYMMDD | 2009-04-01 |
PublicationDate_xml | – month: 04 year: 2009 text: April 2009 |
PublicationDecade | 2000 |
PublicationPlace | Melbourne, Australia |
PublicationPlace_xml | – name: Melbourne, Australia – name: Australia |
PublicationTitle | Pathology international |
PublicationTitleAlternate | Pathol Int |
PublicationYear | 2009 |
Publisher | Blackwell Publishing Asia |
Publisher_xml | – name: Blackwell Publishing Asia |
References | Thesleff I, Jalkanen M, Vainio S, Bernfield M. Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis. Dev Biol 1988; 129: 565-72. Philipsen HP, Reichart PA, Takata T. Desmoplastic ameloblastoma (including 'hybrid' lesion of ameloblastoma). Biological profile based in 100 cases from the literature and own files. Oral Oncol 2001; 37: 455-60. David G, Bai XM, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development 1993; 119: 841-54. Koda J, Rapraeger A, Bernfield M. Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens. J Biol Chem 1985; 260: 4870-77. Inki P, Larjava H, Haapasalmi K, Miettinen HM, Grenman R, Jalkanen M. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur J Cell Biol 1994; 63: 43-51. Vainio S, Jalkanen M, Thesleff I. Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme. J Cell Biol 1989; 108: 1945-54. Lin SC, Lieu CM, Hahn LJ, Kwan HW. Peripheral ameloblastoma with metastasis. Int J Oral Maxillofac Surg 1987; 16: 202-6. Sivapathasundharam B, Einstein A, Syed Rafiuddeen I. Desmoplastic ameloblastoma in Indians. Report of five cases and review of the literature. Indian J Dent Res 2007; 18: 218-21. Sanderson RD, Hinkes MT, Bernfield M. Syndecan-1, a cell surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 1992; 66: 314-23. Slootweg PJ, Müller H. Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol 1984; 57: 168-79. Salmavirta M, Rauvala H, Elenius K, Jalkanen M. Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res 1992; 200: 444-51. Tulumori V, Thomas GA, Fraser IS. The relationship of proliferating cell density at the invasive tumor front with prognostic and risk factors in human oral squamous cell carcinoma. J Oral Pathol Med 2004; 33: 204-8. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729-77. Joensuu H, Anttonen A, Eriksson M et al. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 2002; 62: 5210-17. Zellweger T, Nink C, Mirlacher M et al. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate 2003; 55: 20-29. Gurol M, Burkes EJ Jr. Peripheral ameloblastoma. J Periodontol 1995; 66: 1065-8. El-Mofty SK, Gerard NO, Farsi SE, Rodu B. Peripheral ameloblastoma: A clinical and histologic study of 11 cases. J Oral Maxillofac Surg 1991; 49: 970-76. Kim J, Yook JI. Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas. Eur J Cancer B Oral Oncol 1994; 30B: 126-31. Elenius K, Määttä A, Salmavirta M, Jalkanen M. Growth factors induce 3T3 cells to express bFGF-binding. J Biol Chem 1992; 25: 6435-41. Salmavirta M, Elenius K, Vainio S et al. Syndecan from embryonic tooth mesenquime binds tenascin. J Biol Chem 1991; 266: 7733-39. Saunders S, Bernfield M. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor on interstitial matrix. J Cell Biol 1988; 106: 423-30. Barnes L, Eveson JW, Reichart P, Sidransky D (eds) World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press, 2005. Philipsen HP, Reichart P, Nikai H, Takata T, Kudo Y. Peripheral ameloblastoma: Biological profile based on 160 cases from the literature. Oral Oncol 2001; 37: 17-27. Vainio S, Lehtonen E, Jalkanen M, Bernfield M, Saxen L. Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol 1989; 134: 382-91. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Takamori K. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous carcinoma. J Oral Pathol Med 2006; 35: 301-6. Shah L, Walter K, Borczuk A, Kawut S, Sonett J, Gorestein L. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with non small cell lung carcinoma. Cancer 2004; 101: 1632-8. Anttonen A, Kajanti M, Heikkila P, Jalkanen M, Joensuu H. Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer 1999; 79: 558-64. Ruoshanti E. Proteoglycans in cell regulation. J Biol Chem 1989; 264: 13369-72. Benlyazid A, Lacroix-Triki M, Aziza R, Gomez-Brouchet A, Guichard M, Sarini J. Ameloblastic carcinoma of the maxilla: Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: e17-24. Ledesma C, Mosqueda-Taylor A, Carlos-Bregni R et al. Ameloblastomas: A regional Latin-American multicentric study. Oral Dis 2007; 13: 303-7. Hayashi K, Hayashi M, Jalkanen M, Firestone JH, Trelstad RL, Bernfield M. Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissue. A light and electron microscopic study. J Histochem Cytochem 1987; 35: 1079-88. Leocata P, Villari D, Fazzari C, Lentini M, Fortunato C, Nicotina PA. Syndecan-1 and Wingless-type protein-1 in human ameloblastomas. J Oral Pathol Med 2007; 36: 394-9. Ro Y, Muramatsu T, Shima K et al. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue. Int J Oral Maxillofac Surg 2006; 35: 252-7. Salmavirta M, Mali M, Heino H, Hermonen J, Jalkanen M. A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells. Exp Cell Res 1994; 215: 180-88. David G, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992; 118: 961-69. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E et al. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol 2008; 44: 805-11. 2004; 101 1987; 35 2007; 18 2007; 104 1994; 215 1989; 134 2006; 35 1992; 200 1999; 68 2005 1985; 260 2007; 13 1994; 63 1988; 129 1988; 106 2007; 36 2003; 55 1987; 16 2004; 33 1991; 49 1991; 266 1989; 108 1993; 119 2002; 62 1989; 264 1995; 66 1984; 57 1999; 79 1992; 118 2001; 37 2008; 44 1992; 25 1994; 30B 1992; 66 e_1_2_5_26_2 Elenius K (e_1_2_5_27_2) 1992; 25 e_1_2_5_25_2 e_1_2_5_22_2 e_1_2_5_23_2 e_1_2_5_20_2 Sanderson RD (e_1_2_5_9_2) 1992; 66 e_1_2_5_28_2 e_1_2_5_29_2 e_1_2_5_14_2 e_1_2_5_37_2 e_1_2_5_13_2 Inki P (e_1_2_5_10_2) 1994; 63 e_1_2_5_16_2 e_1_2_5_35_2 e_1_2_5_15_2 Salmavirta M (e_1_2_5_24_2) 1991; 266 e_1_2_5_36_2 e_1_2_5_7_2 e_1_2_5_33_2 e_1_2_5_6_2 e_1_2_5_34_2 e_1_2_5_5_2 e_1_2_5_31_2 e_1_2_5_4_2 e_1_2_5_11_2 e_1_2_5_32_2 e_1_2_5_3_2 Ruoshanti E (e_1_2_5_8_2) 1989; 264 e_1_2_5_18_2 e_1_2_5_17_2 e_1_2_5_19_2 Joensuu H (e_1_2_5_12_2) 2002; 62 e_1_2_5_30_2 Barnes L (e_1_2_5_2_2) 2005 Koda J (e_1_2_5_21_2) 1985; 260 |
References_xml | – volume: 44 start-page: 805 year: 2008 end-page: 11 article-title: Syndecan‐1 (CD138) and Ki‐67 expression in different subtypes of ameloblastomas publication-title: Oral Oncol – volume: 30B start-page: 126 year: 1994 end-page: 31 article-title: Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas publication-title: Eur J Cancer B Oral Oncol – volume: 62 start-page: 5210 year: 2002 end-page: 17 article-title: Soluble syndecan‐1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer publication-title: Cancer Res – year: 2005 – volume: 215 start-page: 180 year: 1994 end-page: 88 article-title: A novel laminin‐binding form of syndecan‐1 (cell surface proteoglycan) produced by syndecan‐1 cDNA‐transfected NIH‐3T3 cells publication-title: Exp Cell Res – volume: 200 start-page: 444 year: 1992 end-page: 51 article-title: Neurite growth‐promoting protein (amphoterin, p30) binds syndecan publication-title: Exp Cell Res – volume: 119 start-page: 841 year: 1993 end-page: 54 article-title: Spatial and temporal changes in the expression of fibroglycan (syndecan‐2) during mouse embryonic development publication-title: Development – volume: 101 start-page: 1632 year: 2004 end-page: 8 article-title: Expression of syndecan‐1 and expression of epidermal growth factor receptor are associated with survival in patients with non small cell lung carcinoma publication-title: Cancer – volume: 37 start-page: 17 year: 2001 end-page: 27 article-title: Peripheral ameloblastoma: Biological profile based on 160 cases from the literature publication-title: Oral Oncol – volume: 129 start-page: 565 year: 1988 end-page: 72 article-title: Cell surface proteoglycan expression correlates with epithelial‐mesenchymal interaction during tooth morphogenesis publication-title: Dev Biol – volume: 36 start-page: 394 year: 2007 end-page: 9 article-title: Syndecan‐1 and Wingless‐type protein‐1 in human ameloblastomas publication-title: J Oral Pathol Med – volume: 55 start-page: 20 year: 2003 end-page: 29 article-title: Tissue microarray analysis reveals prognostic significance of syndecan‐1 expression in prostate cancer publication-title: Prostate – volume: 35 start-page: 301 year: 2006 end-page: 6 article-title: Reduced syndecan‐1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous carcinoma publication-title: J Oral Pathol Med – volume: 260 start-page: 4870 year: 1985 end-page: 77 article-title: Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens publication-title: J Biol Chem – volume: 63 start-page: 43 year: 1994 end-page: 51 article-title: Expression of syndecan‐1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes publication-title: Eur J Cell Biol – volume: 33 start-page: 204 year: 2004 end-page: 8 article-title: The relationship of proliferating cell density at the invasive tumor front with prognostic and risk factors in human oral squamous cell carcinoma publication-title: J Oral Pathol Med – volume: 13 start-page: 303 year: 2007 end-page: 7 article-title: Ameloblastomas: A regional Latin‐American multicentric study publication-title: Oral Dis – volume: 66 start-page: 314 year: 1992 end-page: 23 article-title: Syndecan‐1, a cell surface proteoglycan, changes in size and abundance when keratinocytes stratify publication-title: J Invest Dermatol – volume: 118 start-page: 961 year: 1992 end-page: 69 article-title: Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells publication-title: J Cell Biol – volume: 16 start-page: 202 year: 1987 end-page: 6 article-title: Peripheral ameloblastoma with metastasis publication-title: Int J Oral Maxillofac Surg – volume: 108 start-page: 1945 year: 1989 end-page: 54 article-title: Syndecan and tenascin expression is induced by epithelial‐mesenchymal interactions in embryonic tooth mesenchyme publication-title: J Cell Biol – volume: 37 start-page: 455 year: 2001 end-page: 60 article-title: Desmoplastic ameloblastoma (including ‘hybrid’ lesion of ameloblastoma). Biological profile based in 100 cases from the literature and own files publication-title: Oral Oncol – volume: 18 start-page: 218 year: 2007 end-page: 21 article-title: Desmoplastic ameloblastoma in Indians. Report of five cases and review of the literature publication-title: Indian J Dent Res – volume: 106 start-page: 423 year: 1988 end-page: 30 article-title: Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor on interstitial matrix publication-title: J Cell Biol – volume: 266 start-page: 7733 year: 1991 end-page: 39 article-title: Syndecan from embryonic tooth mesenquime binds tenascin publication-title: J Biol Chem – volume: 68 start-page: 729 year: 1999 end-page: 77 article-title: Functions of cell surface heparan sulfate proteoglycans publication-title: Annu Rev Biochem – volume: 35 start-page: 252 year: 2006 end-page: 7 article-title: Correlation between reduction of syndecan‐1 expression and clinico‐pathological parameters in squamous cell carcinoma of tongue publication-title: Int J Oral Maxillofac Surg – volume: 25 start-page: 6435 year: 1992 end-page: 41 article-title: Growth factors induce 3T3 cells to express bFGF‐binding publication-title: J Biol Chem – volume: 79 start-page: 558 year: 1999 end-page: 64 article-title: Syndecan‐1 expression has prognostic significance in head and neck carcinoma publication-title: Br J Cancer – volume: 35 start-page: 1079 year: 1987 end-page: 88 article-title: Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissue. A light and electron microscopic study publication-title: J Histochem Cytochem – volume: 264 start-page: 13369 year: 1989 end-page: 72 article-title: Proteoglycans in cell regulation publication-title: J Biol Chem – volume: 66 start-page: 1065 year: 1995 end-page: 8 article-title: Peripheral ameloblastoma publication-title: J Periodontol – volume: 57 start-page: 168 year: 1984 end-page: 79 article-title: Malignant ameloblastoma or ameloblastic carcinoma publication-title: Oral Surg Oral Med Oral Pathol – volume: 104 start-page: e17 year: 2007 end-page: 24 article-title: Ameloblastic carcinoma of the maxilla: Case report and review of the literature publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod – volume: 49 start-page: 970 year: 1991 end-page: 76 article-title: Peripheral ameloblastoma: A clinical and histologic study of 11 cases publication-title: J Oral Maxillofac Surg – volume: 134 start-page: 382 year: 1989 end-page: 91 article-title: Epithelial‐mesenchymal interactions regulate the stage‐specific expression of a cell surface proteoglycan, syndecan, in the developing kidney publication-title: Dev Biol – volume-title: World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours year: 2005 ident: e_1_2_5_2_2 contributor: fullname: Barnes L – ident: e_1_2_5_11_2 doi: 10.1038/sj.bjc.6690088 – ident: e_1_2_5_34_2 doi: 10.1111/j.1600-0714.2007.00537.x – ident: e_1_2_5_18_2 doi: 10.1016/S1368-8375(00)00111-1 – volume: 63 start-page: 43 year: 1994 ident: e_1_2_5_10_2 article-title: Expression of syndecan‐1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes publication-title: Eur J Cell Biol contributor: fullname: Inki P – ident: e_1_2_5_33_2 doi: 10.1242/dev.119.3.841 – ident: e_1_2_5_37_2 doi: 10.1016/0964-1955(94)90064-7 – ident: e_1_2_5_14_2 doi: 10.1002/cncr.20542 – ident: e_1_2_5_23_2 doi: 10.1083/jcb.106.2.423 – ident: e_1_2_5_29_2 doi: 10.1016/0012-1606(88)90401-0 – ident: e_1_2_5_7_2 doi: 10.1016/S1368-8375(00)00064-6 – volume: 62 start-page: 5210 year: 2002 ident: e_1_2_5_12_2 article-title: Soluble syndecan‐1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer publication-title: Cancer Res contributor: fullname: Joensuu H – ident: e_1_2_5_25_2 doi: 10.1016/0014-4827(92)90194-D – volume: 66 start-page: 314 year: 1992 ident: e_1_2_5_9_2 article-title: Syndecan‐1, a cell surface proteoglycan, changes in size and abundance when keratinocytes stratify publication-title: J Invest Dermatol contributor: fullname: Sanderson RD – ident: e_1_2_5_26_2 doi: 10.1006/excr.1994.1330 – ident: e_1_2_5_28_2 doi: 10.1177/35.10.2957423 – ident: e_1_2_5_30_2 doi: 10.1016/0012-1606(89)90110-3 – ident: e_1_2_5_5_2 doi: 10.4103/0970-9290.35836 – ident: e_1_2_5_3_2 doi: 10.1111/j.1601-0825.2006.01284.x – ident: e_1_2_5_31_2 doi: 10.1083/jcb.108.5.1945 – ident: e_1_2_5_4_2 doi: 10.1016/j.oraloncology.2007.10.007 – volume: 25 start-page: 6435 year: 1992 ident: e_1_2_5_27_2 article-title: Growth factors induce 3T3 cells to express bFGF‐binding publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)42715-9 contributor: fullname: Elenius K – ident: e_1_2_5_36_2 doi: 10.1111/j.0904-2512.2004.00178.x – ident: e_1_2_5_16_2 doi: 10.1902/jop.1995.66.12.1065 – ident: e_1_2_5_15_2 doi: 10.1111/j.1600-0714.2006.00412.x – volume: 264 start-page: 13369 year: 1989 ident: e_1_2_5_8_2 article-title: Proteoglycans in cell regulation publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)80001-1 contributor: fullname: Ruoshanti E – ident: e_1_2_5_35_2 doi: 10.1016/j.ijom.2005.06.020 – volume: 260 start-page: 4870 year: 1985 ident: e_1_2_5_21_2 article-title: Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)39576-5 contributor: fullname: Koda J – ident: e_1_2_5_13_2 doi: 10.1002/pros.10209 – ident: e_1_2_5_17_2 doi: 10.1016/0278-2391(91)90061-P – ident: e_1_2_5_6_2 doi: 10.1016/S0901-5027(87)80131-5 – volume: 266 start-page: 7733 year: 1991 ident: e_1_2_5_24_2 article-title: Syndecan from embryonic tooth mesenquime binds tenascin publication-title: J Biol Chem doi: 10.1016/S0021-9258(20)89510-6 contributor: fullname: Salmavirta M – ident: e_1_2_5_19_2 doi: 10.1016/0030-4220(84)90207-X – ident: e_1_2_5_20_2 doi: 10.1016/j.tripleo.2007.05.026 – ident: e_1_2_5_32_2 doi: 10.1083/jcb.118.4.961 – ident: e_1_2_5_22_2 doi: 10.1146/annurev.biochem.68.1.729 |
SSID | ssj0017360 |
Score | 2.1278427 |
Snippet | The aims of the present study were to examine whether the pattern of syndecan‐1 expression correlates with cellular proliferation index in desmoplastic... The aims of the present study were to examine whether the pattern of syndecan-1 expression correlates with cellular proliferation index in desmoplastic... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 229 |
SubjectTerms | ameloblastic carcinoma Ameloblastoma - metabolism Ameloblastoma - pathology Carcinoma - metabolism Carcinoma - pathology CD138 Cell Proliferation desmoplastic ameloblastoma Humans Immunohistochemistry Jaw Neoplasms - metabolism Jaw Neoplasms - pathology Ki-67 Ki-67 Antigen - biosynthesis peripheral ameloblastoma Prognosis syndecan-1 Syndecan-1 - biosynthesis |
Title | Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma |
URI | https://api.istex.fr/ark:/67375/WNG-K89NWD27-M/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1440-1827.2009.02355.x https://www.ncbi.nlm.nih.gov/pubmed/19351365 https://search.proquest.com/docview/20546170 https://search.proquest.com/docview/67110449 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB61i1T1UqAPCNDWh4pbULK2Y-dYLa8W7WqlFsEt8isSAhLEdqWVuPAT-I38ko6dZLdbUamqmkPkeGIn8cx4xhn7M8AniTZQmlzFjMsyZszoWCvOYkZlqbhEAxFwZo-_idG53D_wMDlfu7UwDT7E_Ieb14zQX3sFV3rym5KHuGRftLCTfbSde96fxEFDWM1Bx_OAgqCLBcMeAX55Us-TFS1ZqhXf6LOn3NBlrzaYpcPV__lBa_CqdU7J50aa1uGZq17Di2Ebfn8Dd4MFVjhxs3YObUXqknjkA4dserx_SImqLDm5wGQmyEVFPJhyQC-4ChTrJtf1DXrt-BSirt1Vrf2Fn6gU6IsspBu_11GFtLdwenjwfXAct7s3xIbjEZvEqswxpkuj0IPvOzxxQ3mqleWJlZamHLNKaqhRfRug5nJa0kQqkWjt6DvoVXXlNoFwbS1zNi8zi6M3YXKJvQo6dlwox01KI0g7ThU3DUhH8evghmEaW9VvuZkXoVWLWQS7gaXzAur20k9yE7w4Gx0VJzIfne1jmWEEHzueF6h6Pp6iKldPJ1gdSlIqkj_fkQn0rhjLI9hohGXxejm2BM14BFmQib9-72L8ZeRTW_9acBtedhGxJN2B3o_bqXsPzyd2-iGozE_TDxPz |
link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NTtwwEB5RkFouLaUF0pbiQ9VbqmRtx84R8dNFy0ZIpaI3y7EdCQEJYllpJS59BJ6RJ2Hsze52EUgVIofI8cSOY894xh77M8A3iTpQmlzHjMsqZsyUcak5ixmVleYSFUTAme3-EsUfubvnYXJ6k70wY3yI6YSbl4zQX3sB9xPSD6Q8OCY7osWd7KDy_IEG5RLLkC_9fg56NHUpCDrbMuwx4OeX9Tya05yuWvLVPnrMEJ23a4Ni2n_3or-0Am9b-5RsjxnqPSy4ehVe91sP_Ae42ZnBhRM3apfR1qSpiAc_cNhSd39vU6JrS3qnGMwEOa2Jx1MOAAbngWLd4KK5RMMdv0L0hTtvSv_g1yoF-iwK6cYfd1Qj7SP83t873unG7QEOseF4xSaxOnOMlZXRaMR3HN64oTwtteWJlZamHKMqaqjRHRvQ5nJa0URqkZSlo2uwWDe12wDCS2uZs3mVWRzACZNL7FjQtuNCO25SGkE6aSp1OcbpUP-ObxiGsVb9qZu5CrWqRhF8D206TaCvzvw6N8HVSfFT9WRenOximn4EW5NGVyh93qWia9cMB5gdslIqkqffyAQaWIzlEayPuWVWvBxrgmY8giwwxX-XWx0dFD706bkJt-BN97h_qA4Pit5nWJ44yJL0CyxeXw3dJrwa2OHXID_3Rm4YGw |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dTtswFD4aICFu9gss7AdfTLvLlNR27FxOlA5WiCptE7uzHNuRKiCpKJUqccMj7Bn3JDt203admIQQuYgcn9hxbB-fzznOZ4APEm2gNLmOGZdVzJgp41JzFjMqK80lGojAM3v0TRQ_ZffQ0-R8nf8LM-OHWHxw85oRxmuv4CNb_aPkwS_ZES3tZAdt5yfEkxsMUbnn0ad0sPAoCLr8Y9hTwK-u6rkzpxVTteFrfXoXDl2FtcEu9Z495hs9h6ctOiWfZ93pBTxx9UvYPG3976_g5mBJFk7ctF1EW5OmIp76wGE7_b79lRJdW9IfYjATZFgTz6Yc6AsugsS68WUzQtiOTyH60l00pb_wK5WCfBmFcuM3O6pRtg0_eoffD47idvuG2HA8YpNYnTnGyspohPAdhyduKE9LbXlipaUpx6iKGmp0xwauuZxWNJFaJGXp6A6s103tXgPhpbXM2bzKLE7fhMklDiuI7LjQjpuURpDOW0qNZiwd6u_ZDcMw1qrfczNXoVbVNIKPoUkXCfTVuV_lJrg6K76ovsyLsy6mOY1gf97mCnXPO1R07ZrJGLPDnpSK5P93ZALhFWN5BLuzzrIsXo41QTMeQRb6xL3LrQbHhQ_tPTThPmwOuj11clz038DW3DuWpG9h_fpq4t7B2thO3gft-QO7bxbB |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+expression+of+syndecan%E2%80%901+and+Ki%E2%80%9067+in+peripheral+and+desmoplastic+ameloblastomas+and+ameloblastic+carcinoma&rft.jtitle=Pathology+international&rft.au=Bologna%E2%80%90Molina%2C+Ronell&rft.au=Mosqueda%E2%80%90Taylor%2C+Adalberto&rft.au=Lopez%E2%80%90Corella%2C+Eduardo&rft.au=De+Almeida%2C+Oslei+Paes&rft.date=2009-04-01&rft.pub=Blackwell+Publishing+Asia&rft.issn=1320-5463&rft.eissn=1440-1827&rft.volume=59&rft.issue=4&rft.spage=229&rft.epage=233&rft_id=info:doi/10.1111%2Fj.1440-1827.2009.02355.x&rft.externalDBID=10.1111%252Fj.1440-1827.2009.02355.x&rft.externalDocID=PIN2355 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1320-5463&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1320-5463&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1320-5463&client=summon |